Cyclo Therapeutics - Ownership and Business Overview

Life ScienceCompany

Cyclo Therapeutics Ownership

Who owns Cyclo Therapeutics?

.

Cyclo Therapeutics Business Overview

Where is Cyclo Therapeutics headquartered?

Cyclo Therapeutics is headquartered in Gainesville, Florida.

What sector is Cyclo Therapeutics in?

Cyclo Therapeutics is a life science company.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Cyclo Therapeutics

Cyclo Therapeutics, Inc.

6714 NW 16th Street, Suite B,
Gainesville, Florida 32653
United States,
(386) 418-8060
www.cyclotherapeutics.com

Cyclo Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for rare and neurological diseases with limited treatment options. The Company’s investigational Trappsol Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (www.ClinicalTrials.gov NCT02939547, NCT02912793, NCT03893071 and NCT04860960). It is conducting a Phase 2b clinical trial using Trappsol Cyclo intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842). Cyclo Therapeutics is based in Gainesville, Florida


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.